학술논문
SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis
Document Type
Article
Author
Source
In International Immunopharmacology September 2022 110
Subject
Language
ISSN
1567-5769